Actively Recruiting
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Led by Ipsen · Updated on 2026-04-30
150
Participants Needed
28
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will assess how well cabozantinib works and how safe it is in adults with a type of cancer called neuroendocrine tumors (NETs). These tumors can appear in all parts of the body. All participants in this study have already received at least one treatment that affects the whole body to help manage their cancer, but their disease has continued to grow. The study will take place in regular hospitals and clinics in Germany and Austria. It will follow about 150 participants who are taking cabozantinib as part of their usual care. Doctors will collect information from routine medical visits, tests, and scans to see how the cancer responds to treatment and how long participants stay on cabozantinib. They will also look at side effects and how the treatment affects participants' quality of life. This is an observational study, which means that no extra tests or procedures will be done beyond what is normally used to care for participants with this condition.
CONDITIONS
Official Title
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Are 18 years or older and able to give informed consent
- Have a physician-initiated decision to start treatment with cabozantinib for neuroendocrine tumors (NETs), made before joining the study
- Have unresectable or metastatic, well-differentiated pancreatic (pNET) or extra-pancreatic neuroendocrine tumors (epNET)
- Have already received at least one prior systemic therapy, other than somatostatin analogues
- Have signed a written informed consent form
You will not qualify if you...
- Currently participating in an interventional clinical trial, or have done so within the last 3 months before joining this study
- Have a contraindication to cabozantinib treatment, based on the product's official prescribing information
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 28 locations
1
Medizinische Universitaet Graz
Graz, Austria
Not Yet Recruiting
2
Kepler Universitaetsklinikum GmbH Linz
Linz, Austria
Not Yet Recruiting
3
MVZ am Klinikum Aschaffenburg
Aschaffenburg, Germany
Not Yet Recruiting
4
DRK Kliniken Berlin
Berlin, Germany
Not Yet Recruiting
5
Evangelische Lungenklinik Berlin
Berlin, Germany
Actively Recruiting
6
Krankenhaus St. Joseph-Stift Bremen GmbH
Bremen, Germany
Actively Recruiting
7
Klinikum Chemnitz
Chemnitz, Germany
Not Yet Recruiting
8
MVZ fuer Haematologie und Onkologie Koeln am Sachsenring
Cologne, Germany
Not Yet Recruiting
9
pioh Studien und Mangement GbR
Cologne, Germany
Actively Recruiting
10
Gemeinschaftspraxis Haematologie - Onkologie
Dresden, Germany
Actively Recruiting
11
Technische Univiersitaet (TU) Dresden
Dresden, Germany
Not Yet Recruiting
12
Universitaetsklinikum Essen
Essen, Germany
Not Yet Recruiting
13
Krankenhaus Nordwest
Frankfurt, Germany
Not Yet Recruiting
14
Uniklinikum Frankfurt
Frankfurt am Main, Germany
Not Yet Recruiting
15
Universitaetsklinikum Giessen-Marburg
Giesen, Germany
Not Yet Recruiting
16
Universitaetsmedizin Goettingen
Goettigen, Germany
Actively Recruiting
17
Asklepios Kliniken Hamburg
Hamburg, Germany
Not Yet Recruiting
18
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, Germany
Not Yet Recruiting
19
Studienzentrum UnterEms
Leer, Germany
Not Yet Recruiting
20
MVZ Leipzig Mitte, MVZ Delitzsch
Leipzig, Germany
Not Yet Recruiting
21
Universiteatsmedizin Leipzig
Leipzig, Germany
Not Yet Recruiting
22
RKH Kliniken Ludwigsburg-Bietigheim gGmbH
Ludwigsburg, Germany
Actively Recruiting
23
Philipps-Universitaet Marburg
Marburg, Germany
Not Yet Recruiting
24
Johannes Wesling Klinikum Minden der Muehlenkreiskliniken AoeR
Minden, Germany
Not Yet Recruiting
25
MVZ Muelheim an der Ruhr GmbH
Mülheim, Germany
Not Yet Recruiting
26
Universitätsklinikum Tuebingen
Tübingen, Germany
Actively Recruiting
27
Medizinische Studiengesellschaft Nord-West
Westerstede, Germany
Actively Recruiting
28
Universitaetsklinikum Wuerzburg
Würzburg, Germany
Actively Recruiting
Research Team
I
Ipsen Clinical Study Enquiries
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here